Needs Assessment to Guide the Development of a Paediatric Survivorship Programme in Hong Kong
1 other identifier
observational
38
1 country
1
Brief Summary
This study aims to fill the gaps in knowledge regarding the effects of cancer and its treatment on Hong Kong Chinese paediatric cancer survivors, especially during the transition period, to further capture a deeper understanding of the challenges, views and needs of Hong Kong Chinese paediatric cancer survivors and the key stakeholders around them via face-to-face conversations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2022
CompletedFirst Posted
Study publicly available on registry
May 2, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedFebruary 28, 2024
August 1, 2022
1.2 years
January 24, 2022
February 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
An individual, a face-to-face interview will be conducted with the participants to identify the needs of paediatric cancer survivors during the transition period after cancer treatment
Semi-structured and open-ended questions will be used to collect qualitative data from the participants
through study completion, an average of 15 months
An individual, a face-to-face interview will be conducted with the participants to assess the key elements in the development of a paediatric survivorship programme
Semi-structured and open-ended questions will be used to collect qualitative data from the participants
through study completion, an average of 15 months
Study Arms (1)
Interviewees
Paediatric cancer survivors, their parent/caregiver and health care professionals will be invited to express their views and perspectives in an interview with the researcher
Interventions
Not Application as this is a qualitative study
Eligibility Criteria
Paediatric cancer survivors
You may qualify if:
- able to speak Cantonese and read Chinese
- aged between 9 and 18 years of age
- Should have completed cancer treatment between 2 months and 2 years earlier
You may not qualify if:
- Children who received a diagnosis and completed treatment before the age of 9 will be excluded as they might have vague memories of the course of cancer and may have limited verbal and cognitive ability to express themselves
- Children of exclude parents will be exclueded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hong Kong Children's Hospital
Hong Kong, Hong Kong
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Joyce Chung
The Hong Kong Polytechnic University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2022
First Posted
May 2, 2022
Study Start
August 1, 2022
Primary Completion
September 30, 2023
Study Completion
December 1, 2023
Last Updated
February 28, 2024
Record last verified: 2022-08